1
/
of
0
FDA Drug Approval, N217388, WAINUA (AUTOINJECTOR)
FDA Drug Approval, N217388, WAINUA (AUTOINJECTOR)
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
NDA: 217388
Company: ASTRAZENECA AB
Drug Name: WAINUA (AUTOINJECTOR)
Active Ingredients: EPLONTERSEN SODIUM
Strength: EQ 45MG BASE/0.8ML (EQ 45MG BASE/0.8ML)
Dosage Form/Route: SOLUTION;SUBCUTANEOUS
Action Date: 12/21/2023
Marketing Status: Prescription
Submission Classification: Type 1 - New Molecular Entity
Company: ASTRAZENECA AB
Drug Name: WAINUA (AUTOINJECTOR)
Active Ingredients: EPLONTERSEN SODIUM
Strength: EQ 45MG BASE/0.8ML (EQ 45MG BASE/0.8ML)
Dosage Form/Route: SOLUTION;SUBCUTANEOUS
Action Date: 12/21/2023
Marketing Status: Prescription
Submission Classification: Type 1 - New Molecular Entity
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details